Leufkens, H. G. M.

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 1,294

Use of oral corticosteroids and risk of fractures

Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchAdrenal Hormones and Disorders

Cited by 1,263

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.

Staa, T. P. V., Geusens, P., Bijlsma, J. W. J., Leufkens, H. G. M., & Cooper, C. (2006) · Arthritis & Rheumatism

Rheumatoid Arthritis Research and TherapiesBone health and osteoporosis research

Cited by 587

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme

Herings, R. M. C., de Boer, A., Leufkens, H. G. M., Porsius, A., & Stricker, B. H. C. (1995) · The Lancet

Diabetes Management and ResearchBlood Pressure and Hypertension Studies

Cited by 217

Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico

Santa-Ana-Tellez, Y., Mantel-Teeuwisse, A. K., Dreser, A., Leufkens, H. G. M., & Wirtz, V. J. (2013) · PLoS ONE

Antibiotic Use and ResistancePharmaceutical Economics and Policy

Cited by 135

Essential medicines are more available than other medicines around the globe

Bazargani, Y. T., Ewen, M., de Boer, A., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2014) · PLoS ONE

Pharmaceutical Economics and PolicyHealthcare Systems and Reforms

Cited by 126

Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis

Driessen, J. H. M., Henry, R. M. A., van Onzenoort, H. A. W., Lalmohamed, A., Burden, A. M., Prieto-Alhambra, D., Neef, C., Leufkens, H. G. M., & de Vries, F. (2015) · Calcified Tissue International

Diabetes Treatment and ManagementBone health and osteoporosis research

Cited by 79

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

ten Ham, R. M. T., Hövels, A. M., Hoekman, J., Frederix, G. W. J., Leufkens, H. G. M., Klungel, O. H., Jedema, I., Veld, S. A. J., Nikolic, T., Van Pel, M., et al. (2020) · Cytotherapy

Pharmaceutical Economics and PolicyCAR-T cell therapy research

Cited by 73

Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study

Smans, L. C. C. J., Souverein, P. C., Leufkens, H. G. M., Hoepelman, A. I. M., & Zelissen, P. M. J. (2013) · European Journal of Endocrinology

Adrenal Hormones and DisordersPharmacovigilance and Adverse Drug Reactions

Cited by 70

Choice of Comparator in Active Control Trials of New Drugs

Luijn, J. C. V., Loenen, A. C. V., Gribnau, F. W., & Leufkens, H. G. (2008) · Annals of Pharmacotherapy

Statistical Methods in Clinical TrialsPharmaceutical industry and healthcare

Cited by 21